[MYGN] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -390.48%
YoY- -2,842.86%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 93,200 164,000 195,100 186,300 215,400 216,600 216,800 -43.06%
PBT -58,500 -131,100 -11,400 -22,300 -7,700 3,300 3,600 -
Tax -3,000 -15,900 -3,100 -1,700 -3,400 -3,600 1,000 -
NP -55,400 -115,200 -8,300 -20,600 -4,200 6,900 2,600 -
Tax Rate - - - - - 109.09% -27.78% -
Total Cost 148,600 279,200 203,400 206,900 219,600 209,700 214,200 -21.65%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -59.44 -70.24 -4.25 -11.06 -1.95 3.19 1.20 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.74 -1.55 -0.11 -0.28 -0.06 0.09 0.04 -
EPS Diluted -0.74 -1.55 -0.11 -0.28 -0.06 0.09 0.03 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.